RECRUITING

Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation

Description

This is a pilot study to examine the tolerability, safety and early efficacy of two forms of transcranial magnetic stimulation (TMS) for treating adolescents with Obsessive Compulsive Disorder (OCD) who have experienced limited improvements with usual treatments for OCD in adolescents. The project's primary goal is to examine whether adolescents can complete 3 consecutive weeks of TMS administered 5 days per week, and to describe the type of and how common individual side effects with TMS occur in adolescents with OCD. Participants will: * visit the clinic every weekday for 3 weeks (15 days) to receive TMS treatments * have a brain MRI scan before TMS treatments begins and after finishing all TMS * complete questionnaires and report changes in behavior and physical symptoms

Conditions

Obsessive-Compulsive Disorder
Talk to us

Related Conditions:

Obsessive-Compulsive Disorder

Study Overview

On this page

Study Details

Study overview

This is a pilot study to examine the tolerability, safety and early efficacy of two forms of transcranial magnetic stimulation (TMS) for treating adolescents with Obsessive Compulsive Disorder (OCD) who have experienced limited improvements with usual treatments for OCD in adolescents. The project's primary goal is to examine whether adolescents can complete 3 consecutive weeks of TMS administered 5 days per week, and to describe the type of and how common individual side effects with TMS occur in adolescents with OCD. Participants will: * visit the clinic every weekday for 3 weeks (15 days) to receive TMS treatments * have a brain MRI scan before TMS treatments begins and after finishing all TMS * complete questionnaires and report changes in behavior and physical symptoms

Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation

Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation

Condition
Obsessive-Compulsive Disorder
Intervention / Treatment

-

Contacts and Locations

San Francisco

University of California, San Francisco, San Francisco, California, United States, 94107

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. outpatients
  • 2. ages 13 - 17 years
  • 3. meets current DSM-5 criteria for Obsessive Compulsive Disorder with screening CY-BOCS II score \> 16 (moderate to severe).
  • 4. stable on chronic psychotropic medications and/or therapy for 8 weeks prior to the study and agreeable to continue throughout the study without changes.
  • 5. participants may continue to take medications and record daily usage throughout the study.
  • 6. capacity to provide informed assent and parent or legal guardian able to provide consent.
  • 7. ability to tolerate clinical study procedures.
  • 8. successfully complete the screening forms without any contraindications.
  • 1. Psychiatric: history of schizophrenia, bipolar disorder, substance/alcohol abuse disorder, current elevated suicide risk, prior psychosurgery, prior ECT.
  • 2. Neurologic: severe neurocognitive disorder, seizure disorder, certain structural brain lesions (e.g., intracranial mass lesions, hydrocephalus, sequelae of meningitis, frank brain injury).
  • 3. TMS contraindications: implanted device; presence of metal in the head, including eyes and ears (excluding dental implants); certain tics; medications or systemic illness that predispose seizure risk; family history of 1st degree relative with seizure disorder.
  • 4. Subjects with an unstable physical, systemic, or metabolic disorder (e.g., unstable hypertension, malnutrition secondary to eating disorder).
  • 5. Females who are pregnant or nursing (as determined by a questionnaire and pregnancy test).
  • 6. Current and anticipated continued treatment with excluded medication (See prohibited list).
  • 7. Inability to complete the research protocol as determined by the Principal Investigator.

Ages Eligible for Study

13 Years to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

James T McCracken, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2027-07-01